InvestorsHub Logo
Followers 324
Posts 22331
Boards Moderated 0
Alias Born 03/13/2014

Re: None

Friday, 02/28/2020 3:08:47 AM

Friday, February 28, 2020 3:08:47 AM

Post# of 6214
This is exciting stuff on Vaxart.

https://insiderfinancial.com/top-coronavirus-stocks-backed-by-scientific-evidence/179657/

"Vaxart Inc. (NASDAQ: VXRT) has a core competency in oral recombinant protein vaccines but is expanding indications to work on a possible vaccine against Covid-19. Since the vaccine is in the form of a tablet it lends itself to much wider adoption should it be approved. Studies have shown that it is just as effective as the seasonal vaccine Fluzone manufactured by SNY. The market cap is only $80 million so any positive approval news could vault the stock price."

Just as effective as SNY!!! SNY trades at $48 per share with a 10.4 billion market cap. Just sayin!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VXRT News